Upload
shahwan-hussein
View
217
Download
0
Embed Size (px)
Citation preview
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
1/164
Summaryof previous lesson
Macrophage Attacking E.coli (SEM x8,800) Dr Dennis
KunkelAlveolar (Lung) Macrophage Attacking E. coli (SEMx10,000) Dr Dennis Kunkel (used with permission)
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
2/164
Horton & Parker: Informed Infection Control Practice
I. Chain of Infection
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
3/164
HOST DEFENSE
MECHANISMS
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
4/164
Lecture nr. 6
Antigens. Antibodies.Immune response.
Cell cooperation and
mediators in immune
response.
15.03.2011
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
5/164
HOST DEFENSE
MECHANISMS
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
6/164
Immunity: Free from burden. Ability of anorganism to recognize and defend itself againstspecific pathogens or antigens.
Immunity refers to the ability of the human body toresist disease agents and their toxins throughpossession of antibodies.
Immunity is a long lasting protection against a
specific antigen.
Definitions of theImmunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
7/164
Specific Host Defenses:The Immune Response
The structure of immunoglobulinsT-cell (part of the specificimmune response)
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
8/164
The ImmuneResponse
Immune Response: Third line of defense.
Involves production of antibodies and
generation of specialized lymphocytes
against specific antigens.
Antigen: Molecules from a pathogen or
foreign organism that provoke a specific
immune response.
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
9/164
What is the immune
system?
The bodys defense against disease causing
organisms, malfunctioning cells, and foreign
particles
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
10/164
Microbes are recognized by two mechanisms: evolved broad recognition mechanisms (innate
immunity), and by highly specific lymphocyte antibodies and T cell
receptors (adaptive immunity)
Different types of microbes are eliminated bydifferent effectors mechanisms, which aredesigned to best combat each type of microbe
How does the immune system
respond to different infections?
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
11/164
Classification
of immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
12/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
13/164
Classification
of the immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
14/164
A. Naturally Acquired Active Immunity: Antigens or pathogens enter body naturally.
Body generates an immune response to antigens.
Immunity may be lifelong (chickenpox or mumps) or temporary(influenza or intestinal infections).
B. Naturally Acquired Passive Immunity: Antibodies pass from mother to fetus via placenta or breast feeding
(colostrum). No immune response to antigens.
Immunity is usually short-lived (weeks to months).
Protection until childs immune system develops.
Acquired Immunity:Obtained in the course ofdaily life.
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
15/164
Classification
of the immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
16/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
17/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
18/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
19/164
Beneficial:
Protection from Invaders
Elimination of Altered Self
Detrimental:
Discomfort (inflammation)
Damage to self (autoimmunity)
Significance of the
Immune System
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
20/164
Components of HumanImmune System
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
21/164
Cells of the immune system
Lymphocytes Mediators of adaptive immune responses; only cells with
specific receptors for antigens
Antigen-presenting cells (APCs) Specialized to capture, concentrate, and display antigens for
recognition by lymphocytes Dendritic cells; macrophages, B cells; follicular dendritic
cells Different APCs serve different roles in adaptive immune
responses Effector cells
Function to eliminate microbes; include lymphocytes,granulocytes (neutrophils, eosinophils), macrophages
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
22/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
23/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
24/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
25/164
To become mature, immunocompetent cells, they must
pass through lymphoid tissues in other parts of the
body.As they do so, they become committed to becoming
eitherT cells or B cells1. Cells that migrate through the bone marrow (bursalequivalent) become B cells , and will produce antigensand
participate in humoral immunity.
2. Cells that migrate through the thymus glandsbecome T cells and participate in Cell-mediated
Lymphocytes
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
26/164
Congenital immunodeficiency diseases are often caused by blocksat different stages of lymphocyte maturation
LYMPHOCYTE DEVELOPMENT
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
27/164
CD Nomenclature
Structurally defined leukocyte surface molecule thatis expressed on cells of a particular lineage(differentiation) and recognized by a group(cluster) of monoclonal antibodies is called a
member of a cluster of differentiation (CD) CD molecules (CD antigens, CD markers) are: Identified by numbers Used to classify leukocytes into functionally distinct
subpopulations, e.g. helper T cells are CD4+CD8-, CTLs areCD8+CD4-
Often involved in leukocyte functions
Antibodies against various CD molecules are used to: Identify and isolate leukocyte subpopulations Study functions of leukocytes Eliminate particular cell populations
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
28/164
Two types of T cells: coordination of
function with properties of antigen-
presentation
CD4 T cells
.Help other immune cells
Recognize peptide + MHC
II
MHC II is expressedprimarily on immune
cells
Peptides are from
endoc tosed anti en
CD8 T cells
.Kill virus-infected cells
Recognize peptide + MHC
I
MHC I is expressed on
all nucleated cells
Peptides are fromc tosolic anti en
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
29/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
30/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
31/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
32/164
ANTIGENS
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
33/164
An antigen is a molecule that stimulates an immune
response.
The word originated from the notion that they can
stimulate antibody generation.
The modern definition includes all substances that can be
recognized by the adaptive immune system.
Antigens
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
34/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
35/164
Chemical nature of
antigen
Proteins
Polysaccharides
Nucleic acids
Lipids Some glycolipids and phospholipids can be
immunogenic for T cells and illicit a cell-mediated immune response
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
36/164
Most are proteins or large polysaccharides from a
foreign organism. Microbes: Capsules, cell walls, toxins, viral capsids, flagella, etc.
Nonmicrobes: Pollen, egg white , red blood cell surfacemolecules, serum proteins, and surface molecules from
transplanted tissue.
Lipids and nucleic acids are only antigenic when combined
with proteins or polysaccharides.
Molecular weight of 10,000 or higher.
Antigens
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
37/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
38/164
Antigens can be classified in
order of their origins
Exogenous antigens - are antigens that have
entered the body from the outside, ex. by inhalation, ingestion, or injection.
By endocytosis or phagocytosis, these antigens are taken into the
antigen-presenting cells (APCs) and processed into fragments.
Endogenous antigens - antigens that havebeen generated within the cell, as a result
of: normal cell metabolism, or
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
39/164
Allogenic antigen
The specific antigen exists in different individuals.
Blood type antigens.
Autoantigensusually a normal protein (sometimes DNA or RNA) that is
recognized by the immune system of patients sufferingfrom a specific autoimmune disease.
Types of Antigens
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
40/164
Self Antigens Antigens of our own cells
Do not cause an immune response in our
body Usually cause an immune response in another
person
MHC proteins Major Histocompatibility Complex
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
41/164
are presented by the MHC I molecules on the surface of
tumor cells. can sometimes be presented only by tumor cells and
never by the normal ones.
they are called tumor-specific antigens (TSAs) andtypically result from a tumor specific mutation.
Tumor antigens
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
42/164
Characteristics of
AntigenImmunogenicity
The capacity to stimulate the production of
antibodies or cell-mediated immune
responses.
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
43/164
Antigenicity
The ability to bind antibody.
Complete antigen
Incomplete antigen, also known as
hapten.
Hapten: Small foreign molecule that is not antigenic. Must be coupled to a
carrier molecule to be antigenic. Once antibodies are formed they will
recognize hapten.
Characteristics of
Antigen
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
44/164
Epitope or, Antigenic determinants:
Small part of an antigen that interacts with an
antibody. Any given antigen may have several epitopes.
Each epitope is recognized by a different
antibody and may interact with them by
paratopes ofAntibody
Antigens
F
e
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
45/164
Epitopes: Antigen Regions that Interactwith paratopes, Antibodies regions
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
46/164
Types of Epitopes1. Linear epitopes
continuous and found in polysaccharides
as well as in both native (nondenatured) anddenatured proteins, especially fibrillar
proteins.
specificity depends upon primary
sequence.
typical size is 5-6 subunits in length.
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
47/164
2. Conformational epitopes Discontinuous (involve multiple subunits,
often located far apart in the primary
sequence of the antigen molecule) and are
thus found only in native (globular)proteins.
Types of Epitopes
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
48/164
Antigenic epitopes
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
49/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
50/164
Two differentepitopes
B cell epitope, a portion
of antigen molecule thatis recognized by B cell
receptors.
T cell epitope, the
region of antigenmolecules that are
recognized by T cell
receptors.
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
51/164
Antigens: T-independent
Activate B cells without MHCclass II T help
Polysaccharides Properties Polymeric structure Polyclonal B cell activation, but poor
memory Resistance to degradation
Examples Pneumococcal polysaccharide, LPS Flagella
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
52/164
Antigens: T-dependent
Require T help to activate B
cells
Proteins Examples
Microbial proteins
Non-self or altered-self
proteins
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
53/164
Hapten-carrier
conjugates Definition
Ag only if bound to carrier protein
Structure Native determinants
Haptenic determinants
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
54/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
55/164
ANTIBODY
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
56/164
Proteins that recognize and bind to a particular antigenwith very high specificity.
Made in response to exposure to the antigen.
One virus or microbe may have several antigenicdeterminant sites, to which different antibodies may bind.
Each antibody has at least two identical sites that bindantigen: Antigen binding sites.
Valence of an antibody: Number of antigen binding sites.Most are bivalent.
Belong to a group of serum proteins called
immunoglobulins (Igs).
Antibodies
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
57/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
58/164
Monomer: A flexible Y-shaped molecule with fourprotein chains:
2 identical lightchains 2 identical heavy chains
Variable Regions: Two sections at the end of Ys arms.Contain the antigen binding sites (Fab). Identical onthe same antibody, but vary from one antibody toanother.
Constant Regions: Stem of monomer and lower parts ofY arms.
Fc region: Stem of monomer only. Important becausethey can bind to complement or cells.
AntibodyStructure
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
59/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
60/164
Immunoglobulins
IgG - monomer
IgA dimer 2 units
IgM pentamer 5 units IgD monomer
IgE monomer
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
61/164
Structure: Monomer
Percentage serum antibodies: 80%
Location: Blood, lymph, intestine
Half-life in serum: 23 days
Complement Fixation: Yes
Placental Transfer: Yes
Known Functions: Enhances phagocytosis, neutralizes
toxins and viruses, protects fetus and newborn.
I. IgG
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
62/164
Structure: Pentamer
Percentage serum antibodies: 5-10%
Location: Blood, lymph, B cell surface (monomer)
Half-life in serum: 5 days Complement Fixation: Yes
Placental Transfer: No
Known Functions: First antibodies produced during an
infection. Effective against microbes and agglutinating
antigens.
II. IgM
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
63/164
Structure: Dimer
Percentage serum antibodies: 10-15%
Location: Secretions (tears, saliva, intestine, milk), bloodand lymph.
Half-life in serum: 6 days
Complement Fixation: No
Placental Transfer: No
Known Functions: Localized protection ofmucosalsurfaceProvides immunity to infant digestive tract.
III. IgA
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
64/164
Structure: Monomer
Percentage serum antibodies: 0.2%
Location: B-cell surface, blood, and lymph Half-life in serum: 3 days
Complement Fixation: No
Placental Transfer: No
Known Functions: In serum function is unknown. On B ce
surface, initiate immune response.
IV. IgD
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
65/164
Structure: Monomer
Percentage serum antibodies: 0.002%
Location: Bound to mast cells and basophils throughout
body. Blood. Half-life in serum: 2 days
Complement Fixation: No
Placental Transfer: No
Known Functions: Allergic reactions. Possibly lysis ofworms.
V. IgE
Antibodies are Produced by B Lymphocytes
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
66/164
y y p y
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
67/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
68/164
B cells develop from stem cells in the bone marrow of
adults (liver of fetuses).
After maturation B cells migrate to lymphoid organs(lymph node or spleen).
Clonal Selection: When a B cell encounters an antigen it
recognizes, it is stimulated and divides into many clones
called plasma cells, which actively secrete antibodies.
Each B cell produces antibodies that will recognize only
one antigenic determinant.
Secretions theAntibodies by B cells
Clonal Selection of B Cells is Caused by
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
69/164
yAntigenic Stimulation
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
70/164
Programmed cell death (Falling away). Human body makes 100 million lymphocytes
every day. If an equivalent number doesnt die,
will develop leukemia.
B cells that do not encounter stimulating antigen
will self-destruct and send signals to phagocytes
to dispose of their remains.
Many virus infected cells will undergo apoptosis,
to help prevent spread of the infection.
Apoptosis
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
71/164
Immune response
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
72/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
73/164
Involves production of antibodies against foreign antigens.
Antibodies are produced by a subset of lymphocytes called B
cells.
B cells that are stimulated will actively secrete antibodies andare called plasma cells.
Antibodies are found in extracellular fluids (blood plasma,
lymph, mucus, etc.) and the surface of B cells.
Defense against bacteria, bacterial toxins, and viruses that
circulate freely in body fluids, before they enter cells. Also cause certain reactions against transplanted tissue.
I. Humoral (Antibody-Mediated) Immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
74/164
Plasma cells secrete antibodies, which can circulate andinteract with antigen.
Antigens are processed by antigen-presentingcells (lots in lymphoid tissues)- macrophages- dendritic cells
- B cells.MHC plays a critical role in antigenpresentation
Humoral Immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
75/164
How do antibodies actually
help eliminate antigens?
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
76/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
77/164
Antigen-Antibody Complex: Formed whenan antibody binds to an antigen it
recognizes.Affinity: A measure of binding strength.1. Agglutination: Antibodies cause antigens
(microbes) to clump together. IgM (decavalent) is more effective that IgG
(bivalent). Hemagglutination: Agglutination of red blood cells.
Used to determine ABO blood types and to detectinfluenza and measles viruses.
Consequences ofAntigen-AntibodyBinding
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
78/164
Consequences ofAntigen-AntibodyBinding
2. Opsonization: Antigen (microbe) is covered
with antibodies that enhances its ingestion
and lysis by phagocytic cells.
3. Neutralization: IgG inactivates viruses by
binding to their surface and neutralize toxins
by blocking their active sites.
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
79/164
Antibody-dependent cell-mediated cytotoxicity:
Used to destroy large organisms (e.g.: worms).
Target organism is coated with antibodies and
bombarded with chemicals from nonspecific
immune cells.
5. Complement Activation: Both IgG and IgM
trigger the complement system which results in
cell lysis and inflammation.
Consequences ofAntigen-AntibodyBinding
Consequences of Antibody Binding
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
80/164
Consequences of Antibody Binding
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
81/164
Primary Response:
After initialexposure to antigen, no antibodies are
found in serum for several days. A gradual increase in titer, first of IgM and then
of IgG is observed.
Most B cells become plasma cells, but some B cells
become long living memory cells. Gradual decline of antibodies follows.
Immunological responce
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
82/164
Subsequent exposure to the same antigen
displays a faster and more intense antibody
response.
Increased antibody response is due to theexistence of memory cells, which rapidly produce
plasma cells upon antigen stimulation.
Antibody Titer: The amount of antibody in theserum.
Secondary Response:
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
83/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
84/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
85/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
86/164
Duality of ImmuneSystem Humoral (Antibody-
Mediated) Immunity
II. Cellular (CellMediated) Immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
87/164
Involves specialized set of lymphocytes called T cellsthat recognize foreign antigens on the surface of cells,organisms, or tissues:
Helper T cells
Cytotoxic T cells
T cells regulate proliferation and activity of other cellsof the immune system: B cells, macrophages,neutrophils, etc.
Defense against: Bacteria and viruses that are inside host cells and are inaccessible to
antibodies. Fungi, protozoa, and helminths Cancer cells Transplanted tissue
II. Cellular (CellMediated) Immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
88/164
T cells regulate the immune response
Helper T cells secrete cytokines that regulate the immune
response
IL-2 - induce proliferation of T cellsIL-4, IL-5, IL-6 - activate B cells (and T cells)-interferon - T cell activation
IL-1 is secreted by macrophages; this helps activate Tcells also
Macrophages present antigen to T cells
Cellular Immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
89/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
90/164
Matures inbone marrowthymusType of immunityhumoralcell-mediatedSecretesantibodiescytokinesAntigen receptorsurface IgT cell receptorWhere foundspleenblood, lymph
nodesTargetsbacteria, infected cellsvirusestumor cells?Memory?YesYes
B and T cells mediatespecific immunity
B cells T cells
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
91/164
Antigens that stimulate this response are mainly
intracellular.Requires constant presence of antigen to remain effective.
Unlike humoral immunity, cell mediated immunity is nottransferred to the fetus.
Cytokines: Chemical messengers of immune cells.
Over 100 have been identified.
Stimulate and/or regulate immune responses. Interleukins: Communication between WBCs. Interferons: Protect against viral infections.
Chemokines: Attract WBCs to infected areas.
T Cells and CellMediated Immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
92/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
93/164
Cellular Components of Immunity: T cells are key cellular component of immunity.
T cells have an antigen receptor that recognizes
and reacts to a specific antigen (T cell receptor).
T cell receptor only recognize antigens combined
with major histocompatability (MHC) proteins on
the surface of cells. MHC Class I: Found on all cells.
MHC Class II: Found on phagocytes.
Clonal selection increases number of T cells.
T Cells and CellMediated Immunity
T Cells Only Recognize Antigen
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
94/164
T Cells Only Recognize AntigenAssociated with MHC Molecules on Cell
Surfaces
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
95/164
Types of T cells1. T Helper (TH) Cells: Central role in immune
response. Most are CD4+
Recognize antigen on the surface of antigen presenting
cells (e.g.: macrophage).
Activate macrophages Induce formation of cytotoxic T cells
Stimulate B cells to produce antibodies.
Cells and Cell MediatedImmunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
96/164
Central Role of Helper T Cells
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
97/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
98/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
99/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
100/164
1. Activated Macrophages: Stimulated phagocytes. Stimulated by ingestion of antigen
Larger and more effective phagocytes. Enhanced ability to eliminate intracellular bacteria, virus-infected
and cancerous cells.
2. Natural Killer (NK) Cells: Lymphocytes that destroy virus infected and tumor cells.
Not specific. Dont require antigen stimulation.
Not phagocytic, but must contact cell in order to lyse it.
Nonspecific CellularComponents
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
101/164
Cellular Interactions in
the Immune Response
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
102/164
C ll l I t ti i th
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
103/164
Cellular Interactions in theImmune Response
Few antigens can activate B cells all by
themselves
For activation of B cells and Tc Cells need asecond signal cytokine ( cell mover)
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
104/164
Antigen-Presenting cells (macrophages)place antigen on their cell surface in
combination with the MHC II complexAntigen is presented to a specific helper Tcell that has receptors that match theantigen MHC II complex
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
105/164
Cell surfacepeptides
of Ag
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
106/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
107/164
T and B cells recognise antigen differently
Antigen must be catabolised before T cells can recognise it
Antigen processing generates antigenic peptides
Exogenous antigen processing takes place in lysosomes
Endogenous processing is non-lysosomal
The mechanism of antigen processing depends upon thecompartment in which the pathogen replicates
Endogenous and exogenous antigen processing both involveuptake, degradation, complex formation and presentation
Pathogens can evade immunity by disrupting antigen processing
Summary
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
108/164
After binding, the APC produces Interleukin-1 (IL-1) which stimulates the TH Cell to
produce IL-2 and/or IL-4Interleukin-2 has an autocrine function,causes TH Cell to clone itself, and make
more IL-2 and /or IL-4
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
109/164
Helper T cells
TH1 cells produce IL -2 and IFN- and
influence cell-mediated immunity
TH2 cells produce IL -4 (and other ILs)and
influence antibody-mediated (humoral)
immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
110/164
When B cell comes in contact with theantigen and IL-4, the B cell produces plasmacells and memory cellsTc Cells come in contact with the antigen onthe surface of infected cells in combinationwith the MHC 1 complex. When also have
binding with IL-2, cells produce activated TcCells and memory cells.
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
111/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
112/164
Relationship Between Cell-
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
113/164
1. Antibody ProductionT-Dependent Antigens:
Antibody production requires assistance from T helper cells.
A macrophage cells ingest antigen and presents it to TH cell. TH cell stimulates B cells specific for antigen to become plasma cells.
Antigens are mainly proteins on viruses, bacteria, foreign red blood cells,
and hapten-carrier molecules.
T-Independent Antigens: Antibody production does not require assistance from T cells.
Antigens are mainly polysaccharides or lipopolysaccharides withrepeating subunits (bacterial capsules).
Weaker immune response than for T-dependent antigens.
Mediated and HumoralImmunity
Humoral Response to T DependentA ti
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
114/164
Antigens
Humoral Response to T DependentAntigens
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
115/164
Antigens
Principal mechanisms of defense against microbes
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
116/164
Antibodies PhagocytesT cells (CTLs)
(may work with antibodies, T cells)
All microbes
All microbes
Intracellularmicrobes, esp.
viruses
Relationship Between
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
117/164
2. Antibody Dependent Cell Mediated Cytotoxicity Target cell is covered with antibodies, leaving Fc
portion sticking outwards.
Natural killer and other nonspecific cells that have
receptors for Fc region are stimulated to kill targeted
cells.
Target organism is lysed by substances secreted by
attacking cells. Used to destroy large organisms that cannot be
phagocytosed.
Cell-Mediated andHumoral Immunity
Overview of the Immune Response
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
118/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
119/164
Disorders of Immunity
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
120/164
Hypersensitivity
Exaggerated Immune Response
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
121/164
Hypersensitivity Types
Allergy Exogenous, non-human antigen
Isoimmunity (alloimmunity) Exogenous, human antigen
Autoimmunity Endogenous antigen
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
122/164
Type I
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
123/164
Type I
Immediate hypersensitivity IgE mediated
Exogenous antigen
Most (but not all) Allergies
Type I: Mechanism
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
124/164
yp
Repeated antigen exposure causes increased IgEproduction
IgE binds to mast cells
Sensitization occurs
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
125/164
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
126/164
Type I: Signs/Symptoms
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
127/164
Type I: Signs/Symptoms
Clinical signs, symptoms = response to histamine
release
GI, skin, respiratory system High mast cells numbers
Most sensitive
Type I: Signs/Symptoms
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
128/164
ype S g s/Sy pto s
Histamine effects Vasodilatation
Increased capillary permeability
Non-vascular smooth muscle spasm
Type I: Signs/Symptoms
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
129/164
Type I: Signs/Symptoms
Skin: flushing, itching, edema, urticaria Respiratory: bronchospasm, laryngospasm, laryngeal
edema
Cardiovascular: tachycardia, hypotension
GI: nausea, vomiting, cramping, diarrhea
T I At i
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
130/164
Type I: Atopia
Allergy prone individuals
Genetic predisposition
More IgE More mast cell receptors for antibodies than
normal
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
131/164
Type I: Anaphylaxis Severe, generalized Type I reaction
Life-threatening
Loss of airway Ventilatory failure
Hypoperfusion
Type II
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
132/164
yp
Tissue specific Reaction to tissue-specific antigens
Causes target cell destruction, dysfunction
Exogenous or endogenous antigen
T II
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
133/164
Type II
Most commonly affected cells Red blood cells
Thyroid cells
Type II: Mechanisms
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
134/164
Type II: Mechanisms
Antibody binds to cell membrane, triggers
compliment-mediated lysis
Examples Reaction to transfused blood Hemolytic disease of newborn
Type II: Mechanisms
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
135/164
Type II: Mechanisms
Antibodies promote target cell clearance by
macrophages
Type II: Mechanisms
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
136/164
Type II: Mechanisms
Antibodies bind to target cells and cytotoxic
T-cells
Trigger release of toxins to destroy targetcells
Type II: Mechanisms
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
137/164
ype ec a s s
Antibody binds to cell membrane, causes alterations intarget cell function
Example: Graves' disease Antibody binds to thyroid cell membrane
Mimics Thyroid Stimulating Hormone action
Causes production of excessive amounts of thyroid hormone Results in common form of hyperthyroidism
T pe III
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
138/164
Type III
Mediated by antigen/ antibody complex
deposition in tissues
Exogenous or endogenous antigen
Type III: Mechanism
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
139/164
yp
Ag-Ab complex deposited in tissues
Especially sensitive tissues are blood vessels, GI,
respiratory system Causes complement activation, increased
neutrophil activity
Neutrophils have trouble digesting complexes,
release lysosomes causing damage
Type III
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
140/164
yp
Immune complex quantity varies over time Symptomatic periods alternate with periods of
remission
Type III: Serum Sickness
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
141/164
Type III: Serum Sickness
Repeated intravenous antigen injections
Immune complexes deposited in tissues
Fever, rash, pain, lymphadenopathy
Type III: Raynauds
Phenomenon
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
142/164
Phenomenon
Temperature governs immune complexdeposition in peripheral circulation
Exposure to cold causes redness, pain of fingers,
toes followed by numbness, cyanosis, gangrene
Type III: Arthus Reaction
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
143/164
Occurs after repeated LOCAL exposure to
exogenous antigen
Immune complexes in vessel walls
Examples Celiac disease from wheat protein
Hemorrhagic alveolitis from moldy hay inhalation
Type IV
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
144/164
Delayed
Mediated by Td (lymphokine-producing) or Tc
(cytotoxic) cells
No antibody involved
Type IV
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
145/164
Examples Graft rejection Contact allergic reactions (poison ivy)
Hypersensitivity Targets
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
146/164
Hypersensitivity Targets
Allergins Pollen (hay fever)
Drug reactions Foods
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
147/164
Autoimmune Disease
Clinical disorder produced byimmune response to normal tissue
component of patients body
Graves Disease
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
148/164
Graves Disease
Antibody stimulates thyroid hormone over
production
Produces hyperthyroidism Antibody, disease can be passed through
placenta
Rheumatoid Arthritis
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
149/164
Rheumatoid Arthritis
Antibody reaction to collagen in joints
Causes inflammation, destruction of joints
Myasthenia Gravis
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
150/164
Myasthenia Gravis
Antibodies destroy acetylcholine receptors
on skeletal muscle
Produce episodes of severe weakness Antibodies can cross placenta, affect
newborn
Immune Thrombocytopenic
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
151/164
Purpura
Antibodies destroy platelets
Produces clotting disorders, hemorrhaging
Antibodies can cross placenta, affectnewborn
Isoimmune Neutropenia
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
152/164
Isoimmune Neutropenia
Antibodies attack, destroy neutrophils
Can cross placenta, affect newborn
Other Autoimmune Diseases
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
153/164
Other Autoimmune Diseases
Type I diabetes mellitus
Primary myxedema
Rheumatic fever
Crohns disease
Ulcerative colitis
Systemic Lupus Erythematosis (SLE)
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
154/164
Immunodeficiency Disease
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
155/164
Immunodeficiency Disease
Patient unable to fight off infection
Hallmarks
Repeated infections Opportunistic infections
Immunodeficiency Disease
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
156/164
Immunodeficiency Disease
Most are defects in T cells or B cells T cells, macrophage defects = fungal, viral
infections B cells, complement defects = bacterial
infections
Immunodeficiency Disease
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
157/164
Immunodeficiency Disease
Congenital
Acquired
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
158/164
B Cell Deficiency
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
159/164
B Cell Deficiency
Agammaglobulinemia
Hypogammaglobulinemia
IgA Deficiency
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
160/164
IgA Deficiency
Most common immune deficiency disorder
Genetic condition
Failure of IgA synthesis Patient has repeated, recurrent sinus, lung, GI
infections
DiGeorges Syndrome
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
161/164
DiGeorge s Syndrome
Thymic hypoplasia
Severe decrease in T-cell production,
function Defects of face, ears, heart
Severe CombinedI d fi i
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
162/164
Immunodeficiency
Thymus development arrested at ~6-8 weeks
gestation.
Deficiency, defective maturation of stem cells
that produce B and T cells Little to no antibody production
Acquired
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
163/164
Acquired
Nutritional deficiency
Iatrogenic (drugs, radiation)
Trauma (prolonged hypoperfusion) Stress
Infection (HIV)
Immune Deficiency Therapies
8/2/2019 Lecture Nr. 6, Immunity, 16.03.11
164/164
Immune Deficiency Therapies
B-cell deficiency: Gamma globulin
SCID: Bone marrow transplants, enzyme
replacement DiGeorges Syndrome: Fetal thymus
transplants
Gene therapy